Effect of Berberine on Proinflammatory Cytokine Production by ARPE-19 Cells following Stimulation with Tumor Necrosis Factor-α

2012 ◽  
Vol 53 (4) ◽  
pp. 2395 ◽  
Author(s):  
Qian Wang ◽  
Jian Qi ◽  
Ranran Hu ◽  
Ying Chen ◽  
Aize Kijlstra ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Proinflammatory Cytokine ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Cytokine Production ◽  
Proinflammatory Cytokine Production ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia

2020 ◽  
Vol 295 (10) ◽  
pp. 3099-3114
Author(s):  
Nina E. Murugina ◽  
Anna S. Budikhina ◽  
Yulia A. Dagil ◽  
Polina V. Maximchik ◽  
Lyudmila S. Balyasova ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Tumor Necrosis Factor ◽  
Proinflammatory Cytokine ◽  
Tumor Necrosis ◽  
Cytokine Production ◽  
Glucose Starvation ◽  
Proinflammatory Cytokine Production ◽  
Unfolded Protein ◽  
Protein Response ◽  
Necrosis Factor

Upon activation with pathogen-associated molecular patterns, metabolism of macrophages and dendritic cells is shifted from oxidative phosphorylation to aerobic glycolysis, which is considered important for proinflammatory cytokine production. Fragments of bacterial peptidoglycan (muramyl peptides) activate innate immune cells through nucleotide-binding oligomerization domain (NOD) 1 and/or NOD2 receptors. Here, we show that NOD1 and NOD2 agonists induce early glycolytic reprogramming of human monocyte-derived macrophages (MDM), which is similar to that induced by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide. This glycolytic reprogramming depends on Akt kinases, independent of mTOR complex 1 and is efficiently inhibited by 2-deoxy-d-glucose (2-DG) or by glucose starvation. 2-DG inhibits proinflammatory cytokine production by MDM and monocyte-derived dendritic cells activated by NOD1 or TLR4 agonists, except for tumor necrosis factor production by MDM, which is inhibited initially, but augmented 4 h after addition of agonists and later. However, 2-DG exerts these effects by inducing unfolded protein response rather than by inhibiting glycolysis. By contrast, glucose starvation does not cause unfolded protein response and, in normoxic conditions, only marginally affects proinflammatory cytokine production triggered through NOD1 or TLR4. In hypoxia mimicked by treating MDM with oligomycin (a mitochondrial ATP synthase inhibitor), both 2-DG and glucose starvation strongly suppress tumor necrosis factor and interleukin-6 production and compromise cell viability. In summary, the requirement of glycolytic reprogramming for proinflammatory cytokine production in normoxia is not obvious, and effects of 2-DG on cytokine responses should be interpreted cautiously. In hypoxia, however, glycolysis becomes critical for cytokine production and cell survival.

Sign in / Sign up

Export Citation Format

Share Document